Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 18 studies | 41% ± 20% | |
endothelial cell | 18 studies | 44% ± 17% | |
fibroblast | 13 studies | 36% ± 11% | |
GABAergic neuron | 11 studies | 50% ± 25% | |
oligodendrocyte precursor cell | 11 studies | 32% ± 12% | |
glutamatergic neuron | 11 studies | 59% ± 22% | |
pericyte | 9 studies | 30% ± 14% | |
adipocyte | 9 studies | 54% ± 18% | |
ciliated cell | 7 studies | 42% ± 23% | |
interneuron | 6 studies | 56% ± 23% | |
retinal cone cell | 6 studies | 49% ± 26% | |
neuron | 5 studies | 55% ± 20% | |
epithelial cell | 5 studies | 32% ± 21% | |
smooth muscle cell | 5 studies | 30% ± 6% | |
type I pneumocyte | 5 studies | 33% ± 5% | |
type II pneumocyte | 5 studies | 27% ± 3% | |
capillary endothelial cell | 4 studies | 55% ± 26% | |
hepatic stellate cell | 3 studies | 36% ± 20% | |
GABAergic interneuron | 3 studies | 61% ± 11% | |
GABAergic amacrine cell | 3 studies | 37% ± 9% | |
amacrine cell | 3 studies | 38% ± 18% | |
ependymal cell | 3 studies | 57% ± 11% | |
adventitial cell | 3 studies | 27% ± 11% | |
basal cell | 3 studies | 34% ± 14% | |
club cell | 3 studies | 43% ± 15% | |
myofibroblast cell | 3 studies | 38% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2672.10 | 459 / 459 | 94% | 5.57 | 1052 / 1118 |
thymus | 100% | 2327.15 | 652 / 653 | 94% | 4.30 | 567 / 605 |
lung | 100% | 3273.69 | 578 / 578 | 87% | 2.92 | 1009 / 1155 |
brain | 87% | 1985.09 | 2307 / 2642 | 100% | 8.92 | 704 / 705 |
prostate | 100% | 2391.47 | 245 / 245 | 85% | 2.50 | 426 / 502 |
kidney | 93% | 986.65 | 83 / 89 | 89% | 3.68 | 801 / 901 |
skin | 97% | 1496.47 | 1761 / 1809 | 81% | 4.20 | 381 / 472 |
esophagus | 97% | 3534.66 | 1401 / 1445 | 81% | 2.95 | 148 / 183 |
pancreas | 76% | 631.81 | 248 / 328 | 96% | 4.52 | 170 / 178 |
ovary | 100% | 2315.90 | 180 / 180 | 70% | 1.68 | 302 / 430 |
bladder | 100% | 4147.10 | 21 / 21 | 68% | 2.06 | 342 / 504 |
uterus | 100% | 4663.98 | 170 / 170 | 68% | 3.07 | 310 / 459 |
stomach | 96% | 2311.60 | 346 / 359 | 61% | 2.15 | 174 / 286 |
intestine | 97% | 4119.29 | 937 / 966 | 50% | 1.28 | 261 / 527 |
adrenal gland | 38% | 260.38 | 98 / 258 | 80% | 3.59 | 185 / 230 |
adipose | 100% | 3459.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2644.81 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 75% | 837.08 | 650 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 1.99 | 33 / 45 |
eye | 0% | 0 | 0 / 0 | 61% | 1.66 | 49 / 80 |
liver | 16% | 110.31 | 37 / 226 | 27% | 0.58 | 109 / 406 |
spleen | 42% | 317.43 | 102 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 0.53 | 8 / 29 |
muscle | 19% | 131.89 | 155 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 2.76 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | PRICKLE2 |
Protein name | Prickle planar cell polarity protein 2 Prickle-like protein 2 |
Synonyms | |
Description | |
Accessions | Q7Z3G6 C9JY03 A0A1X7SBR1 ENST00000295902.11 ENST00000564377.6 ENST00000638394.2 ENST00000498162.2 |